Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $157 - $205
4 Added 0.07%
6,140 $250,000
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $2,087 - $2,725
50 Added 0.82%
6,136 $314,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $3,588 - $4,380
82 Added 1.37%
6,086 $265,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $8,829 - $10,941
193 Added 3.32%
6,004 $294,000
Q4 2021

Mar 10, 2022

BUY
$41.32 - $61.25 $240,110 - $355,923
5,811 New
5,811 $277,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.